Sorlie T, Tibshirani R, Parker J, Hastie T, Marron JS, Nobel A, et al. Repeated observation of breast tumour subtypes in independent gene expression data sets. Proc Natl Acad Sci USA. 2003;100:8418–23. https://doi.org/10.1073/pnas.0932692100.
Article CAS PubMed PubMed Central Google Scholar
Kim MJ, Ro JY, Ahn SH, Kim HH, Kim SB, Gong G. Clinicopathologic significance of the basal-like subtype of breast cancer: a comparison with hormone receptor and Her2/neu-overexpressing phenotypes. Hum Pathol. 2006;37:1217–26. https://doi.org/10.3349/ymj.2010.51.6.864.
Article CAS PubMed Google Scholar
Mersin H, Yildirim E, Berberoglu U, Gulben K. The prognostic importance of triple-negative breast carcinoma. Breast. 2008;17:341–6. https://doi.org/10.1016/j.breast.2007.11.031.
Tan PH, Ellis I, Allison K, Brogi E, Fox SB, Lakhani S, et al. The 2019 World Health Organization classification of tumours of the breast. Histopathology. 2020;77(2):181–5. https://doi.org/10.1111/his.14091.
Halvorsen TB, Seim E. Association between invasiveness, inflammatory reaction, desmoplasia and survival in colorectal cancer. J Clin Pathol. 1989;42:162–6. https://doi.org/10.1136/jcp.42.2.162.
Article CAS PubMed PubMed Central Google Scholar
Schurch W, Lagace R, Seemayer TA. Myofibroblastic stromal reaction in retracted scirrhous carcinoma of the breast. Surg Gynecol Obstet. 1982;154:351–8.
Shimosato Y, Suzuki A, Hashimoto T, Nishiwaki Y, Kodama T, Yoneyama T, Kameya T. Prognostic implications of fibrotic focus (scar) in small peripheral lung cancer. Am J Surg Pathol. 1980;4:365–73. https://doi.org/10.1097/00000478-198008000-00005.
Article CAS PubMed Google Scholar
Breuninger H, Schaumburg-Lever G, Holzshuh J, Horny HP. Desmoplastic squamous cell carcinoma of skin and vermilion surface. A highly malignant subtype of skin cancer. Cancer. 1996;79:915–9.
Kajiyama K, Maeda T, Takenaka K, Sugimach K, Tsuneyoshi M. The significance of stromal desmoplasia in intrahepatic cholangiocarcinoma. A special reference of ‘scirrhous-type’ and ‘non scirrhous-type’ growth. Am J Surg Pathol. 1999;23:892–902. https://doi.org/10.1097/00000478-199908000-00006.
Article CAS PubMed Google Scholar
Mesker WE, Junggeburt JM, Szuhai K, de Heer P, Morreau H, Tanke HJ, Tollenaar RA. The carcinoma-stromal ratio of colon carcinoma is an independent factor for survival compared to lymph node status and tumour stage. Cell Oncol. 2007;29(5):387–98. https://doi.org/10.1155/2007/175276. (PMID: 17726261).
Article PubMed PubMed Central Google Scholar
Ahn S, Cho J, Sung J, Lee JE, Nam SJ, Kim KM, Cho EY. The prognostic significance of tumour-associated stroma in invasive breast carcinoma. Tumour Biol. 2012;33(5):1573–80. https://doi.org/10.1007/s13277-012-0411-6.
Park JH, Richards CH, McMillan DC, Horgan PG, Roxburgh CS. The relationship between tumour stroma percentage, the tumour microenvironment and survival in patients with primary operable colorectal cancer. Ann Oncol. 2014;25(3):644–51. https://doi.org/10.1093/annonc/mdt593.
Article CAS PubMed PubMed Central Google Scholar
Wang K, Ma W, Wang J, Yu L, Zhang X, Wang Z, et al. Tumour-stroma ratio is an independent predictor for survival in esophageal squamous cell carcinoma. J Thorac Oncol. 2012;7(9):1457–61. https://doi.org/10.1097/JTO.0b013e318260dfe8.
Kuroda H, Tamaru J, Sakamoto G, Ohnisi K, Itoyama S. Immunophenotype of lymphocytic infiltration in medullary carcinoma of the breast. Virchows Arch. 2005;446(1):10–4. https://doi.org/10.1007/s00428-004-1143-9.
Jamiyan T, Kuroda H, Yamaguchi R, Abe A, Hayashi M. CD68- and CD163-positive tumour-associated macrophages in triple negative cancer of the breast. Virchows Arch. 2020;477:767–75. https://doi.org/10.1007/s00428-020-02855-z.
Article CAS PubMed PubMed Central Google Scholar
Barsky SH, Gopalakrishna R. Increased invasion and spontaneous metastasis of BL6 melanoma with inhibition of the desmoplastic response in C57 BL/6 mice. Cancer Res. 1987;47:1663–7.
Nakanishi H, Oguri K, Takenaga K, Hosoda S, Okayama M. Differential fibrotic stromal response of host tissue to low- and high-metastatic cloned lewis lung carcinoma cells. Lab Invest. 1994;70:324–32.
Allison KH, Hammond MEH, Dowsett M, McKernin SE, Carey LA, Fitzgibbons PL, et al. Oestrogen and progesterone receptor testing in breast cancer: ASCO/CAP guideline update. J Clin Oncol. 2020;38(12):1346–66. https://doi.org/10.1200/JCO.19.02309.
Shin N, Son GM, Shin DH, Kwon MS, Park BS, Kim HS, et al. Cancer-associated fibroblasts and desmoplastic reactions related to cancer invasiveness in patients with colorectal cancer. Ann Coloproctol. 2019;35(1):36–46. https://doi.org/10.3393/ac.2018.09.10.
Article PubMed PubMed Central Google Scholar
Ueno H, Kanemitsu Y, Sekine S, Ishiguro M, Ito E, Hashiguchi Y, Kondo F, Shimazaki H, Mochizuki S, Kajiwara Y, Shinto E, Yamamoto J. Desmoplastic pattern at the tumor front defines poor-prognosis subtypes of colorectal cancer. Am J Surg Pathol. 2017;41:1506–12. https://doi.org/10.1097/PAS.0000000000000946. (PMID: 28877064).
Salgado R, Denkert C, Demaria S, Sirtaine N, Klauschen F, Pruneri G, et al. The evaluation of tumour-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014. Ann Oncol. 2015;26:259–71. https://doi.org/10.1093/annonc/mdu450.
Article CAS PubMed Google Scholar
Loi S, Drubay D, Adams S, Pruneri G, Francis PA, Lacroix-Triki M, et al. Tumour-infiltrating lymphocytes and prognosis: a pooled individual patient analysis of early-stage triple-negative breast cancers. J Clin Oncol. 2019;37:559–69. https://doi.org/10.1200/JCO.18.01010.
Article PubMed PubMed Central Google Scholar
Ueno H, Jones AM, Wilkinson KH, Jass JR, Talbot IC. Histological categorisation of fibrotic cancer stroma in advanced rectal cancer. Gut. 2004;53:581–6. https://doi.org/10.1136/gut.2003.028365.
Article CAS PubMed PubMed Central Google Scholar
Zhai Q, Fan J, Lin Q, Liu X, Li J, Hong R, Wang S. Tumor stromal type is associated with stromal PD-L1 expression and predicts outcomes in breast cancer. PLoS ONE. 2019;14(10):0223325. https://doi.org/10.1371/journal.pone.0223325.
Yanai H, Yoshikawa K, Ishida M, Tsuta K, Sekimoto M, Sugie T. Presence of myxoid stromal change and fibrotic focus in pathological examination are prognostic factors of triple-negative breast cancer: results from a retrospective single-center study. PLoS ONE. 2021;16(2): e0245725. https://doi.org/10.1371/journal.pone.0245725.
Article CAS PubMed PubMed Central Google Scholar
Jamiyan T, Kuroda H, Yamaguchi R, Nakazato Y, Noda S, Onozaki M, et al. Prognostic impact of a tumour-infiltrating lymphocyte subtype in triple negative cancer of the breast. Breast Cancer. 2020;27:880–92. https://doi.org/10.1007/s12282-021-01227-y.
Kuroda H, Jamiyan T, Yamaguchi R, Kakumoto A, Abe A, Harada O, Masunaga A. Tumour-infiltrating B cells and T cells correlate with postoperative prognosis in triple-negative carcinoma of the breast. BMC Cancer. 2021;21:286. https://doi.org/10.1186/s12885-021-08009-x.
Article CAS PubMed PubMed Central Google Scholar
Kuroda H, Jamiyan T, Yamaguchi R, Kakumoto A, Abe A, Harada O, Masunaga A. Prognostic value of tumour-infiltrating B lymphocytes and plasma cells in triple-negative breast cancer. BMC Cancer. 2021;21:286. https://doi.org/10.1007/s00428-020-02855-z.
留言 (0)